Techbio Tailor Bio has published a pivotal study demonstrating the power of chromosomal instability (CIN) signatures to predict resistance to widely used chemotherapy drugs across multiple cancer types. The study, carried out in collaboration with the University of Cambridge and the Spanish National Cancer… Read More
A new study has shown that non-cancerous cells positioned close to tumours can affect how cancer responds to treatment. The researchers say factoring in the effects of these cells could improve drug development and provide new insights into the most effective use of existing cancer medications. … Read More
Researchers at Stanford University have revealed new insights related to pancreatic cancer’s resistance to chemotherapy. In a new paper, the scientists revealed that its resistance is related to both the physical stiffness of the tissue around the cancerous cells and the chemical makeup… Read More
Chemotherapy becomes less effective because healthy cells push cancer cells to grow more slowly, according to the findings of two studies from University College London (UCL) and Yale University. Bowel cancer kills over 900,000 people a year and is the second highest cause of cancer mortality… Read More
An update on the latest oncology developments by DDW Digital Content Editor Diana Spencer The last month has seen huge strides forward in our understanding of cancers, particularly in how they develop resistance to therapies and how we can ‘outsmart’ them using gene editing or different therapeutic pathways, but also… Read More
A team from the University of Geneva (UNIGE) has found a way to overcome chemotherapy resistance in colorectal cancer. The team successfully used a combination of tyrosine kinase inhibitors, opening up new avenues for developing therapies that are more targeted than chemotherapy. Colorectal cancer is… Read More
Not only is October Breast Cancer Awareness Month but October 21 is Wear it Pink 2022, Breast Cancer Now’s annual fundraising day. While advances in treatment over the last few years have resulted in good overall survival rates for patients with non-metastatic disease (90% five-year survival rate in the US1),… Read More
